Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
STAAR Surgical
STAA
STAAR Surgical
Growing Myopia And Aging Population Will Expand Vision Correction Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
08 May 25
Updated
08 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$28.00
2.2% undervalued
intrinsic discount
08 Aug
US$27.39
Loading
1Y
-25.4%
7D
1.4%
Author's Valuation
US$28.0
2.2% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$28.0
2.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-95m
445m
2014
2017
2020
2023
2025
2026
2028
Revenue US$445.1m
Earnings US$126.5m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
14.26%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.53%
Calculation
US$126.53m
Earnings '28
x
13.76x
PE Ratio '28
=
US$1.74b
Market Cap '28
US$1.74b
Market Cap '28
/
50.71m
No. shares '28
=
US$34.32
Share Price '28
US$34.32
Share Price '28
Discounted to 2025 @ 7.53% p.a.
=
US$27.61
Fair Value '25